Colzyx is led by a highly qualified, interdisciplinary team with broad experience in life science and research successes published in peer-reviewed journals. Along with the proven track record in bioscience research, our team is highly skilled in business development and project management.

Dr Karin Bryder,
CEO, co-founder

Karin has a vast experience from startup companies in life sciences. Her work spans from research and method development of vaccines and virus diagnostics through protein pharmaceuticals, small molecule development and patent portfolio management. Karin has in the last few years worked extensively with medical device development as project manager and CEO. Karin is a co- founder of Colzyx and the CEO of Colzyx.

Dr Matthias Mörgelin,
CSO, co-founder

Matthias is the key inventor to Colzyx’ patent applications and has discovered the unique properties of human collagen VI. Matthias holds a PhD in Natural Sciences from Basel University and has more than 30 years of academic experience in life science. Matthias is a founder of Colzyx and the CTO of Colzyx.

Jens Hansson,
Acting CFO and BD, Chairman of the Board

Jens has two decades of experience from private equity and venture capital investments. He is an engineer by trade and has prior to his career within the finance sector acted for 10 years in leading industrial positions. Jens also has experience as CEO for a publicly traded company. Jens has been involved in Colzyx since 2019 holding different board positions.

Ulrika Andersson
Director Quality and Regulatory Management

Ulrika is well experienced within the field of quality and regulatory management for medical devices, from design and development to commercialisation. She has built several Quality Management Systems and managed registration of products in the EU and US. She has a BSc in Chemical Engineering from Lund´s Faculty of Engineering (LTH). Ulrika is Director Quality and Regulatory Management of Colzyx.